These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 10491009

  • 21. Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation.
    Pinchuk LM, Klaus SJ, Magaletti DM, Pinchuk GV, Norsen JP, Clark EA.
    J Immunol; 1996 Nov 15; 157(10):4363-70. PubMed ID: 8906811
    [Abstract] [Full Text] [Related]

  • 22. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
    Brossart P, Zobywalski A, Grünebach F, Behnke L, Stuhler G, Reichardt VL, Kanz L, Brugger W.
    Cancer Res; 2000 Aug 15; 60(16):4485-92. PubMed ID: 10969796
    [Abstract] [Full Text] [Related]

  • 23. CD40 ligand is a T cell growth factor.
    Armitage RJ, Tough TW, Macduff BM, Fanslow WC, Spriggs MK, Ramsdell F, Alderson MR.
    Eur J Immunol; 1993 Sep 15; 23(9):2326-31. PubMed ID: 7690330
    [Abstract] [Full Text] [Related]

  • 24. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI, Croft M.
    J Immunol; 1997 Sep 01; 159(5):2282-91. PubMed ID: 9278317
    [Abstract] [Full Text] [Related]

  • 25. Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease.
    Di Sabatino A, Rovedatti L, Kaur R, Spencer JP, Brown JT, Morisset VD, Biancheri P, Leakey NA, Wilde JI, Scott L, Corazza GR, Lee K, Sengupta N, Knowles CH, Gunthorpe MJ, McLean PG, MacDonald TT, Kruidenier L.
    J Immunol; 2009 Sep 01; 183(5):3454-62. PubMed ID: 19648266
    [Abstract] [Full Text] [Related]

  • 26. CD40 ligand acts as a costimulatory signal for neonatal thymic gamma delta T cells.
    Ramsdell F, Seaman MS, Clifford KN, Fanslow WC.
    J Immunol; 1994 Mar 01; 152(5):2190-7. PubMed ID: 7510740
    [Abstract] [Full Text] [Related]

  • 27. Expression of CD40 and CD40 ligand in the human conjunctival epithelium.
    Bourcier T, De Saint-Jean M, Brignole F, Goguel A, Baudouin C.
    Invest Ophthalmol Vis Sci; 2000 Jan 01; 41(1):120-6. PubMed ID: 10634610
    [Abstract] [Full Text] [Related]

  • 28. Differential expression of CD40 ligand on T cell subsets. Implications for different roles of CD45RA+ and CD45RO+ cells in IgE production.
    Patel HR, Oshiba A, Jeppson JD, Gelfand EW.
    J Immunol; 1996 Mar 01; 156(5):1781-87. PubMed ID: 8596027
    [Abstract] [Full Text] [Related]

  • 29. CD40 ligand/CD40 stimulation regulates the production of IFN-gamma from human peripheral blood mononuclear cells in an IL-12- and/or CD28-dependent manner.
    McDyer JF, Goletz TJ, Thomas E, June CH, Seder RA.
    J Immunol; 1998 Feb 15; 160(4):1701-7. PubMed ID: 9469427
    [Abstract] [Full Text] [Related]

  • 30. An increased number of CD40-high monocytes in patients with Crohn's disease.
    Sawada-Hase N, Kiyohara T, Miyagawa J, Ueyama H, Nishibayashi H, Murayama Y, Kashihara T, Nakahara M, Miyazaki Y, Kanayama S, Nezu R, Shinomura Y, Matsuzawa Y.
    Am J Gastroenterol; 2000 Jun 15; 95(6):1516-23. PubMed ID: 10894589
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions.
    Miyashita T, McIlraith MJ, Grammer AC, Miura Y, Attrep JF, Shimaoka Y, Lipsky PE.
    J Immunol; 1997 May 15; 158(10):4620-33. PubMed ID: 9144474
    [Abstract] [Full Text] [Related]

  • 33. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.
    Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D, Targan SR.
    J Immunol; 1997 Dec 15; 159(12):6276-82. PubMed ID: 9550432
    [Abstract] [Full Text] [Related]

  • 34. Immune mechanisms in chronic inflammatory bowel disease.
    Braegger CP, MacDonald TT.
    Ann Allergy; 1994 Feb 15; 72(2):135-41. PubMed ID: 8109803
    [Abstract] [Full Text] [Related]

  • 35. TNF-alpha, not CD154 (CD40L), plays a major role in SEB-dependent, CD4(+) T cell-induced endothelial cell activation in vitro.
    Baum D, Yaron R, Yellin MJ.
    Cell Immunol; 1998 Nov 25; 190(1):12-22. PubMed ID: 9826442
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
    Borges L, Miller RE, Jones J, Ariail K, Whitmore J, Fanslow W, Lynch DH.
    J Immunol; 1999 Aug 01; 163(3):1289-97. PubMed ID: 10415026
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.
    Corral LG, Haslett PA, Muller GW, Chen R, Wong LM, Ocampo CJ, Patterson RT, Stirling DI, Kaplan G.
    J Immunol; 1999 Jul 01; 163(1):380-6. PubMed ID: 10384139
    [Abstract] [Full Text] [Related]

  • 40. Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation.
    Ford GS, Barnhart B, Shone S, Covey LR.
    J Immunol; 1999 Apr 01; 162(7):4037-44. PubMed ID: 10201926
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.